news

Jan 28 2015
AnaMar Announces Strategic Realignment and 2015 Corporate Priorities

Jan 28 2015
Gynecologic Oncology Group (GOG) Phase 2 Study of Advaxis's Lm-LLO Immunotherapy, ADXS-HPV, for the Treatment of Persistent or Recurrent Cervical Cancer Achieves Safety and Efficacy Criteria

Jan 28 2015
Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference


 

events

Jan 17-21 2015
Society of Critical Care Medicine Annual Congress

Jan 18-21 2015
Noble Financial Capital Markets 11th Annual Investor Conference

Jan 28-30 2015
Drug Delivery Partnerships

Feb 9-10 2015
BIO CEO & Investor Conference

Feb 23-24 2015
3rd Annual Sachs Cancer Bio Partnering & Investment Forum


 

spotlight